These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 16972178)

  • 1. Portal hypertension in a patient with Hunter disease.
    Kato T; Isogai K; Orii K; Kuratsubo I; Kondo N; Orii T; Suzuki Y
    J Inherit Metab Dis; 2006 Oct; 29(5):686. PubMed ID: 16972178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First experience of enzyme replacement therapy with idursulfase in Spanish patients with Hunter syndrome under 5 years of age: case observations from the Hunter Outcome Survey (HOS).
    Alcalde-Martín C; Muro-Tudelilla JM; Cancho-Candela R; Gutiérrez-Solana LG; Pintos-Morell G; Martí-Herrero M; Munguira-Aguado P; Galán-Gómez E
    Eur J Med Genet; 2010; 53(6):371-7. PubMed ID: 20709629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucopolysaccharidosis type II in females: case report and review of literature.
    Tuschl K; Gal A; Paschke E; Kircher S; Bodamer OA
    Pediatr Neurol; 2005 Apr; 32(4):270-2. PubMed ID: 15797184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentation and diagnosis of mucopolysaccharidosis type 2 (Hunter syndrome).
    Patil R; Wasekar N; Jadhav SG; Zore R; Sangoi P; Vishwanathan D
    J Assoc Physicians India; 2013 Aug; 61(8):574-6. PubMed ID: 24818348
    [No Abstract]   [Full Text] [Related]  

  • 5. Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome).
    Martin R; Beck M; Eng C; Giugliani R; Harmatz P; Muñoz V; Muenzer J
    Pediatrics; 2008 Feb; 121(2):e377-86. PubMed ID: 18245410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The reliability of death certification in patients dying with mucopolysaccharidosis type II (Hunter syndrome).
    Seshadri D; Jones S; Burt K; Lavery L; Wraith JE
    Clin Genet; 2011 Jun; 79(6):599-600. PubMed ID: 21542835
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic counselling for Hunter syndrome.
    Epstein CJ; Yatziv S; Neufeld E; Liebaers I
    Lancet; 1976 Oct; 2(7988):737-8. PubMed ID: 61412
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prenatal diagnosis of Hunter syndrome in a carrier and her twin sisters].
    Sakai N; Saito T; Hayashi Y; Hiroi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Jan; 48(1):65-8. PubMed ID: 8576624
    [No Abstract]   [Full Text] [Related]  

  • 9. Idursulfase enzyme replacement therapy in an adult patient with severe Hunter syndrome having a novel mutation of iduronate-2-sulfatase gene.
    Christianto A; Watanabe H; Nakajima T; Inazu T
    Clin Chim Acta; 2013 Aug; 423():66-8. PubMed ID: 23726270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter: Question raised regarding diagnosis of Hunter syndrome.
    Kelly TE
    Pediatrics; 1974 Oct; 54(4):522-3. PubMed ID: 4213222
    [No Abstract]   [Full Text] [Related]  

  • 11. Skin rash with the histological absence of metachromatic granules as the presenting feature of Hunter syndrome in a 6-year-old boy.
    Sakata S; Orchard D; Mason G
    Br J Dermatol; 2008 Jul; 159(1):249-50. PubMed ID: 18489604
    [No Abstract]   [Full Text] [Related]  

  • 12. Picture of the month. Hunter syndrome (mucopolysaccharidosis IIA).
    Knoell KA; Tunnessen WW
    Arch Pediatr Adolesc Med; 2000 Jan; 154(1):85-6. PubMed ID: 10632258
    [No Abstract]   [Full Text] [Related]  

  • 13. Intrauterine diagnosis of the hurler and hunter syndromes.
    Fratantoni JC; Neufeld EF; Uhlendorf BW; Jacobson CB
    N Engl J Med; 1969 Mar; 280(13):686-8. PubMed ID: 4179670
    [No Abstract]   [Full Text] [Related]  

  • 14. [Detection of a new mutation (T1140C)in a Chinese Guangdong patient with hunter syndrome].
    Guo YB; Du CS
    Yi Chuan; 2006 May; 28(5):521-4. PubMed ID: 16735228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extension of the molecular analysis to the promoter region of the iduronate 2-sulfatase gene reveals genomic alterations in mucopolysaccharidosis type II patients with normal coding sequence.
    Brusius-Facchin AC; Abrahão L; Schwartz IV; Lourenço CM; Santos ES; Zanetti A; Tomanin R; Scarpa M; Giugliani R; Leistner-Segal S
    Gene; 2013 Sep; 526(2):150-4. PubMed ID: 23707223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The characterization of a murine model of mucopolysaccharidosis II (Hunter syndrome).
    Garcia AR; Pan J; Lamsa JC; Muenzer J
    J Inherit Metab Dis; 2007 Nov; 30(6):924-34. PubMed ID: 17876721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucopolysaccharidosis type II: identification of 30 novel mutations among Latin American patients.
    Brusius-Facchin AC; Schwartz IV; Zimmer C; Ribeiro MG; Acosta AX; Horovitz D; Monlleó IL; Fontes MI; Fett-Conte A; Sobrinho RP; Duarte AR; Boy R; Mabe P; Ascurra M; de Michelena M; Tylee KL; Besley GT; Garreton MC; Giugliani R; Leistner-Segal S
    Mol Genet Metab; 2014 Feb; 111(2):133-8. PubMed ID: 24125893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Basis of Mucopolysaccharidosis Type II and Construction of a Database of Mutant Iduronate 2-Sulfatases.
    Saito S; Ohno K; Okuyama T; Sakuraba H
    PLoS One; 2016; 11(10):e0163964. PubMed ID: 27695081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of the Hunter syndrome with progeny.
    DiFerrante N; Nichols BL
    Johns Hopkins Med J; 1972 May; 130(5):325-8. PubMed ID: 4622960
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of a mnemonic screening tool for identifying subjects with Hunter syndrome.
    Cohn GM; Morin I; Whiteman DA;
    Eur J Pediatr; 2013 Jul; 172(7):965-70. PubMed ID: 23468122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.